C4ORF43 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.546800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.874200E-01
Normal-vs-Stage2
5.519000E-01
Normal-vs-Stage3
5.375600E-01
Normal-vs-Stage4
5.969600E-01
Stage1-vs-Stage2
6.578600E-01
Stage1-vs-Stage3
6.176000E-01
Stage1-vs-Stage4
3.762200E-01
Stage2-vs-Stage3
7.727400E-01
Stage2-vs-Stage4
3.616400E-01
Stage3-vs-Stage4
3.350200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.703800E-01
Normal-vs-AfricanAmerican
6.404800E-01
Normal-vs-Asian
2.795000E-01
Caucasian-vs-AfricanAmerican
8.315400E-01
Caucasian-vs-Asian
3.664800E-01
AfricanAmerican-vs-Asian
3.920200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.194400E-01
Normal-vs-Female
6.225000E-01
Male-vs-Female
4.087400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.544200E-02
Normal-vs-Age(41-60Yrs)
6.971400E-01
Normal-vs-Age(61-80Yrs)
5.000600E-01
Normal-vs-Age(81-100Yrs)
8.805000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.540160E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.472600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.252500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.267400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.392000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.842200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.650200E-01
Normal-vs-Daily Drinker
3.378000E-01
Normal-vs-Weekly Drinker
5.655200E-01
Normal-vs-Occasional Drinker
6.290800E-01
Normal-vs-Social Drinker
7.868800E-01
Non Drinker-vs-Daily Drinker
5.209000E-01
Non Drinker-vs-Weekly Drinker
9.958600E-01
Non Drinker-vs-Occasional Drinker
7.484800E-01
Non Drinker-vs-Social Drinker
5.271800E-01
Daily Drinker-vs-Weekly Drinker
6.352000E-01
Daily Drinker-vs-Occasional Drinker
4.128800E-01
Daily Drinker-vs-Social Drinker
2.981000E-01
Weekly Drinker-vs-Occasional Drinker
8.074400E-01
Weekly Drinker-vs-Social Drinker
6.356600E-01
Occasional Drinker-vs-Social Drinker
7.752600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.127200E-01
Normal-vs-Grade 2
6.137400E-01
Normal-vs-Grade 3
2.127400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.542100E-03
Grade 1-vs-Grade 3
2.149800E-02
Grade 1-vs-Grade 4
5.127200E-01
Grade 2-vs-Grade 3
4.413000E-01
Grade 2-vs-Grade 4
6.137400E-01
Grade 3-vs-Grade 4
2.127400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.356600E-01
Normal-vs-NonDiabetic
4.414600E-01
Diabetic-vs-NonDiabetic
7.545600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.600000E-01
Normal-vs-NoPancreatitis
5.305800E-01
Pancreatitis-vs-NoPancreatitis
8.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.261200E-01
Normal-vs-N1
5.182200E-01
N0-vs-N1
5.779800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.728000E-01
Normal-vs-TP53-NonMutant
5.229600E-01
TP53-Mutant-vs-TP53-NonMutant
1.128180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
